Cart

Looks like your cart is empty!

Time to start your shopping

Return to shop

About us

ATGC Inc. (ATGC) is “A Translational Genomics Company”. The company is dedicated to the development of novel transgenic rabbits as discovery platforms and bioreactors for therapeutic biologics such as monoclonal antibodies.

News

ATGC awarded NIH Phase I STTR grant to develop novel egg bioreactor technology

May 30, 2022

ATGC awarded NIH Phase II STTR grant to continue developing miCas9 technology

April 29, 2022

Contact us

Phone610-337-0269
Administration and R&D:1004 W 9th Avenue, Suite 10
King of Prussia, PA 19406